Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Inventory (2016 - 2025)

Historic Inventory for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $1.5 million.

  • Arcadia Biosciences' Inventory rose 7449.1% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 7449.1%. This contributed to the annual value of $904000.0 for FY2024, which is 800.48% up from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Inventory is $1.5 million, which was up 7449.1% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, Arcadia Biosciences' Inventory peaked at $5.4 million during Q3 2021, and registered a low of $835000.0 during Q3 2024.
  • Over the past 5 years, Arcadia Biosciences' median Inventory value was $2.6 million (recorded in 2023), while the average stood at $2.5 million.
  • In the last 5 years, Arcadia Biosciences' Inventory surged by 20074.63% in 2021 and then crashed by 6908.98% in 2024.
  • Over the past 5 years, Arcadia Biosciences' Inventory (Quarter) stood at $4.4 million in 2021, then plummeted by 47.64% to $2.3 million in 2022, then tumbled by 63.94% to $837000.0 in 2023, then grew by 8.0% to $904000.0 in 2024, then skyrocketed by 61.17% to $1.5 million in 2025.
  • Its Inventory was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.3 million in Q1 2025.